Gaia Barazzetti

EPFL AVP-R REO
BI A2 407 (Bâtiment BI)
Station 7
1015 Lausanne

Expertise

I am a moral philosopher with expertise in the fields of ethics and science and technology policy. I have extensive experience in research ethics compliance and a broad knowledge of the ethical and regulatory frameworks applicable to various areas of research, including research involving human subjects, animal research, research integrity, data management, data protection, pharmaceuticals and medical devices, conflicts of interests, and dual-use research.
My research works address issues of public interest in the areas of biomedical research, healthcare innovation, digitalization, sustainability and emerging technologies, with a strong commitment to stakeholder and public engagement, policy impact, and public outreach.
My teaching activities aim to improve student's abilities to assess and address ethical issues in research and to improve compliance with the ethical standards.

Mission

As Research Ethics Compliance Officer my mission is to support EPFL research community in all ethics related issues of research projects.
My responsibilities are threefold:
  • Ensuring the proper implementation of ethics guidance at all steps of research, from the assessment of ethical issues, to ethics authorization applications, to research ethics policy development.
  • Liasing with the internal Human Research Ethics Committee (HREC) and fostering collaboration with external institutional partners (cantonal ethics commissions, funding bodies, etc.).
  • Raising awareness of ethical standards in research and promoting an ethical culture of compliance at EPFL.

Publications représentatives

Research participant perceptions of personal utility in disclosure of individual research results from genomic analysis

Bogaert B., Crevier M.J., Roth C., Jox R., Barazzetti G.
Published in Journal of Community Genetics 15 (2024):529-538 in

When good science can turn out bad: Addressing dual-use issues in bioethics education

Barazzetti, G.
Published in Bioethica Forum 14(1) 2021: 94-99 in

Making personalized medicine ethical: A critical examination of the new promises of personalized health in Switzerland

Barazzetti G., Bühler N., Audétat M., Kaufmann A.
Published in Science and Public Policy 48(6) 2021: 818-828 in

Dossier électronique du patient: coffre-fort, poubelle à pdf, ou partenariat innovant entre professionnels et patients?

Barazzetti G., Bugnon B., Von Plessen C., Bischoff T., Kaufmann A.
Published in Revue Médicale Suisse 17 2021: 230-233 in

Citizen responses to government restrictions in Switzerland during the COVID-19 pandemic: cross-sectional

Selby K., Durand M.-A., Gouveia A., Bosisio F., Barazzetti G., Hostettler M., D’Acremont V., Kaufmann A., von Plessen C.
Published in JMIR 4(12) 2020: e20871 in

Broad consent in practice: Lessons learned from a hospital-based biobank for prospective research on genomic and medical data

Bosisio F., Barazzetti G., Koutaissoff D., Spencer B.
Published in European Journal of Human Genetics 28(7) 2020: 915-924 in

Adapting preclinical benchmarks for first-in-human trials of hESC- based therapies

Barazzetti G., Hurst S., Mauron A.
Published in Stem Cells Translational Medicine 5(8) 2016: 1058-1066 in